Siegel RL, Miller KD, Fedewa SA et al (2017) Colorectal cancer statistics, 2017. CA: Cancer J Clin 67(3):177–193

Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 71(3):209–249

Segnan N, Armaroli P (2017) Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications. Cancer 123(24):4767–4769

Article  PubMed  Google Scholar 

Marcuello M, Vymetalkova V, Neves RPL et al (2019) Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med 69:107–122

Article  CAS  PubMed  Google Scholar 

Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA: Cancer J Clin 72(5):409–436

Li N, Lu B, Luo C et al (2021) Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America. Cancer Lett 522:255–268

Article  CAS  PubMed  Google Scholar 

Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41(1):49–61

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36–50

Article  CAS  PubMed  Google Scholar 

Chen D, Zhang X, Li Z, Zhu B (2021) Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages. Theranostics 11(3):1016–1030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. International journal of molecular sciences. Jun 29 2021;22(13).

Han S, Wang W, Wang S et al (2021) Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Theranostics 11(6):2892–2916

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan Y, Yu Y, Wang X, Zhang T (2020) Tumor-associated macrophages in tumor immunity. Front Immunol 11:583084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lonardi S, Scutera S, Licini S et al (2020) CSF1R is required for differentiation and migration of Langerhans cells and Langerhans cell histiocytosis. Cancer Immunol Res 8(6):829–841

Article  CAS  PubMed  Google Scholar 

Rao R, Han R, Ogurek S et al (2022) Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition. Neuro Oncol 24(4):584–597

Article  CAS  PubMed  Google Scholar 

Ji P, Gong Y, Jin ML et al (2022) In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer. Sci Adv 8(26):eabl8247

Min AKT, Mimura K, Nakajima S et al (2021) Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer. Cancer Immunol, Immunother : CII 70(2):289–298

Article  CAS  PubMed  Google Scholar 

Porta C, Ippolito A, Consonni FM et al (2018) Protumor steering of cancer inflammation by p50 NF-κB enhances colorectal cancer progression. Cancer Immunol Res 6(5):578–593

Article  CAS  PubMed  Google Scholar 

Biller LH, Schrag D (2021) Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325(7):669–685

Article  CAS  PubMed  Google Scholar 

Ding X, Huang R, Zhong Y et al (2020) CTHRC1 promotes gastric cancer metastasis via HIF-1α/CXCR4 signaling pathway. Biomed Pharmacother 123:109742

Kim JH, Baek TH, Yim HS et al (2013) Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features. Pathol Oncol Res : POR 19(4):731–737

Article  CAS  PubMed  Google Scholar 

Li J, Wang Y, Ma M et al (2019) Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling. EBioMedicine 40:43–55

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang XL, Hu LP, Yang Q et al (2021) CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-β receptors in colorectal cancer. Oncogene 40(23):3959–3973

Article  CAS  PubMed  Google Scholar 

Jiang N, Cui Y, Liu J et al (2016) Multidimensional roles of collagen triple helix repeat containing 1 (CTHRC1) in malignant cancers. J Cancer 7(15):2213–2220

LeClair R, Lindner V (2007) The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor, beta signaling. Trends Cardiovasc Med 17(6):202–205

Article  CAS  PubMed  Google Scholar 

Qin S, Zheng JH, Xia ZH, Qian J, Deng CL, Yang SL (2019) CTHRC1 promotes wound repair by increasing M2 macrophages via regulating the TGF-β and notch pathways. Biomed Pharmacother 113:108594

Mei D, Zhu Y, Zhang L, Wei W (2020) The role of CTHRC1 in regulation of multiple signaling and tumor progression and metastasis. Mediators Inflamm

Wong HY, Sheng Q, Hesterberg AB et al (2022) Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nat Commun 13(1):6036

Ni S, Ren F, Xu M et al (2018) CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer. Cancer Med 7(11):5643–5654

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958):577–584

Article  CAS  PubMed  Google Scholar 

Zheng L, Liang H, Zhang Q et al (2022) circPTEN1, a circular RNA generated from PTEN, suppresses cancer progression through inhibition of TGF-β/Smad signaling. Mol Cancer 21(1):41

Wang X, Lai Q, He J et al (2019) LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci 16(1):51–59

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo Z, Zhang X, Zhu H et al (2021) TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2. Oncol Rep 45(2):523–534

Article  CAS  PubMed  Google Scholar 

Cassetta L, Pollard JW (2018) Targeting macrophages: therapeutic approaches in cancer. Nature reviews. Drug Discov 17(12):887–904

Jaynes JM, Sable R, Ronzetti M et al (2020) Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci Transl Med 12(530)

Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555

Article  CAS  PubMed  Google Scholar 

Sial N, Ahmad M, Hussain MS et al (2021) CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes. Sci Rep 11(1):19873

Qin R, Ren W, Ya G et al (2022) Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. Clin Exp Med

Yin X, Han S, Song C et al (2019) Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells. Cell Oncol (Dordr) 42(4):459–475

Article  CAS  PubMed  Google Scholar 

Guo T, Hajdu M, Agaram NP et al (2009) Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance. Clin Cancer Res 15(22):6862–6870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammond WA, Swaika A, Mody K (2016) Pharmacologic resistance in colorectal cancer: a review. Therapeutic Advances in Medical Oncology 8(1):57–84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woolston A, Khan K, Spain G et al (2019) Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer. Cancer Cell 36(1):35–50.e39

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao L, Wang W, Niu P, Luan X, Zhao D, Chen Y (2022) The molecular mechanisms of CTHRC1 in gastric cancer by integrating TCGA, GEO and GSA datasets. Front Genet 13:900124

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nature reviews. Immunology 19(6):369–382

Timperi E, Gueguen P, Molgora M et al (2022) Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Can Res 82(18):3291–3306

Article  CAS  Google Scholar 

Mao X, Xu J, Wang W et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20(1):131

Tang PC, Chung JY, Xue VW et al (2022) Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition. Adv Sci (Weinheim, Baden-Wurttemberg, Germany) 9(1):e2101235

Kobayashi H, Gieniec KA, Lannagan TRM et al (2022) The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology 162(3):890–906

Article  CAS  PubMed  Google Scholar 

Liu LZ, Zhang Z, Zheng BH et al (2019) CCL15 Recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma. Hepatology (Baltimore, Md.) 69(1):143–159

Itatani Y, Kawada K, Fujishita T et al (2013) Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Gastroenterology 145(5):1064–1075.e1011

Article  CAS  PubMed  Google Scholar 

Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z (2019) TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res: CR 38(1):159

Inamoto S, Itatani Y, Yamamoto T et al (2016) Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through the CCL15-CCR1 chemokine axis. Clin Cancer Res : Offic J Am Assoc Cancer Res 22(2):492–501

Article  CAS  PubMed  Google Scholar